Syndromic Retinopathy
Gene: OPA3
Mutations in OPA3 can impart distinct phenotypes carried through dominant or recessive inheritance patterns but with the common universal feature of optic atrophy (PMID: 31928268). There is intra- and interfamilial variability in age of onset and presenting symptoms (PMID: 25159689). Loss of function is a known mechanism of disease in this gene and is associated with 3-methylglutaconic aciduria, type III (MIM#258501) (PMID: 31928268). The precise mechanism for missense is unknown, however it was suggested they could cause dominant Optic atrophy 3 with cataract (MIM#165300) through either dominant negative or gain of function mechanism (PMID: 31119193). Two transcripts: transcript variant 2 (exon 1 plus exon 2 [NM_025136.3]) and transcript variant 1 (exon 1 plus exon 3 [NM_001017989.2]), where transcript 2 is the predominant one in most tissues.Created: 29 Jan 2021, midnight | Last Modified: 29 Jan 2021, midnight
Panel Version: 0.6119
Mode of inheritance
BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal
Phenotypes
3-methylglutaconic aciduria, type III (MGA3) (MIM#258501), AR; Optic atrophy 3 with cataract (MIM#165300), AD
Publications
Mode of pathogenicity
Other
gene: OPA3 was added gene: OPA3 was added to Syndromic Retinopathy. Sources: Expert Review Green,RetNet Mode of inheritance for gene: OPA3 was set to MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown Phenotypes for gene: OPA3 were set to Autosomal Dominant Optic Atrophy